HEALTH
- Share via
Heart Products Makers Agree to Merge: In a $13.9-million definitive agreement, Cardiotronics Systems Inc. and R2 Medical Systems Inc. said Cardiotronics will begin a tender offer within five days for all outstanding common shares of R2 Medical for $5.25 each in cash. Carlsbad, Calif.-based Cardiotronics said it will purchase 1 million R2 Medical common shares from Ventana Growth Fund II LP at $6.50 each following the tender offer. R2 designs, develops and manufactures a line of disposable self-adhesive cardiac electrode pads used to administer electrical shocks to patients in cardiac arrest. Cardiotronics develops and manufactures disposable emergency medical devices.
More to Read
Inside the business of entertainment
The Wide Shot brings you news, analysis and insights on everything from streaming wars to production — and what it all means for the future.
You may occasionally receive promotional content from the Los Angeles Times.